A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General Population

被引:4
作者
Bourgonje, Arno R. [1 ,2 ]
Bourgonje, Martin F. [3 ]
Gemert, Sacha la Bastide-van [4 ]
Nilsen, Tom [5 ]
Hidden, Clara [5 ]
Gansevoort, Ron T. [6 ]
Mulder, Douwe J. [7 ]
Hillebrands, Jan-Luuk [3 ]
Bakker, Stephan J. L. [6 ]
Dullaart, Robin P. F. [8 ]
van Goor, Harry [3 ]
Abdulle, Amaal E. [7 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, POB 30-001, NL-9700 RB Groningen, Netherlands
[2] Icahn Sch Med Mt Sinai, Dept Med, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[5] Gentian AS, Moss, Norway
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Div Vasc Med, Dept Internal Med, Groningen, Netherlands
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Endocrinol, Groningen, Netherlands
关键词
biomarker; calprotectin; chronic kidney disease; epidemiology; inflammation; population science; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; OXIDATIVE STRESS; DISEASE; INFLAMMATION; ALBUMINURIA; NEUTROPHILS; MYELOID-RELATED-PROTEIN-8/14; EPIDEMIOLOGY; HYPERTENSION;
D O I
10.1016/j.ekir.2024.02.1392
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Systemic inflammation has been associated with chronic kidney disease (CKD). In this study, we aimed to investigate a potential association between the plasma biomarker of inflammation calprotectin and new -onset CKD in a population -based cohort study. Methods: Individuals without CKD at baseline (n = 4662) who participated in the Prevention of REnal and Vascular ENd-stage Disease (PREVEND) prospective population -based cohort study in the Netherlands were included. Baseline plasma calprotectin levels were assessed in samples that had been stored at -80 degrees C. Occurrence of new -onset CKD was defined as a composite outcome of an estimated glomerular filtration rate (eGFR) <60 ml/min per 1.73 m(2), urinary albumin excretion (UAE) >30 mg/24h, or both. Results: Baseline median (interquartile range) plasma calprotectin levels were 0.49 (0.35-0.68) mg/l and baseline median eGFR was 95.9 (interquartile range: 85.0-105.7) ml/min per 1.73 m(2). After median followup of 8.3 (7.8-8.9) years, 467 participants developed new -onset CKD. Baseline plasma calprotectin levels were significantly associated with an increased risk of new -onset CKD (hazard ratio [HR] per doubling 1.28 [95% confidence interval, CI: 1.14-1.44], P < 0.001), independent of potentially confounding factors (HR 1.14 [95% CI: 1.01-1.29], P = 0.034), except for baseline high -sensitive C -reactive protein (hs-CRP) (HR 1.05 [0.91-1.21], P = 0.494). In secondary analyses, the association between plasma calprotectin and occurrence of UAE >30 mg/24h remained significant (HR 1.17 [1.02-1.34], P = 0.027), but not significantly so for the incidence of eGFR <60 ml/min per 1.73 m2 as individual outcome (HR 1.15 [0.92-1.43], P = 0.218). Conclusion: Higher plasma calprotectin levels are associated with an increased risk of developing CKD in the general population. This association is mitigated after adjustment for hs-CRP, and more pronounced with new -onset CKD defined by UAE.
引用
收藏
页码:1265 / 1275
页数:11
相关论文
共 53 条
[31]   Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type [J].
Mylemans, Marnix ;
Nevejan, Louis ;
Van Den Bremt, Stefanie ;
Stubbe, Muriel ;
Cruyssen, Bert Vander ;
Moulakakis, Christina ;
Berthold, Heike ;
Konrad, Christian ;
Bossuyt, Xavier ;
Van Hoovels, Lieve .
CLINICA CHIMICA ACTA, 2021, 517 :149-155
[32]   Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes [J].
Nilsen, Tom ;
Haugen, Siri Helen ;
Larsson, Anders .
HEALTH SCIENCE REPORTS, 2018, 1 (05)
[33]   Determinants of Increased Serum Calprotectin in Patients with Type 2 Diabetes Mellitus [J].
Oosterwijk, Milou M. ;
Bakker, Stephan J. L. ;
Nilsen, Tom ;
Navis, Gerjan ;
Laverman, Gozewijn D. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) :1-11
[34]   Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients [J].
Pedersen, Lise ;
Nybo, Mads ;
Poulsen, Mikael Kjaer ;
Henriksen, Jan Erik ;
Dahl, Jordi ;
Rasmussen, Lars Melholt .
BMC CARDIOVASCULAR DISORDERS, 2014, 14
[35]   Predicting the 30-Year Risk of Cardiovascular Disease The Framingham Heart Study [J].
Pencina, Michael J. ;
D'Agostino, Ralph B., Sr. ;
Larson, Martin G. ;
Massaro, Joseph M. ;
Vasan, Ramachandran S. .
CIRCULATION, 2009, 119 (24) :3078-U61
[36]   Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients [J].
Peng, Wen Hui ;
Jian, Wei Xia ;
Li, Hai Ling ;
Hou, Lei ;
Wei, Yi Dong ;
Li, Wei Ming ;
Xu, Ya Wei .
CARDIOVASCULAR DIABETOLOGY, 2011, 10
[37]   Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study [J].
Post, Adrian ;
Kremer, Daan ;
Swarte, J. Casper ;
Sokooti, Sara ;
Vogelpohl, Fabian A. ;
Groothof, Dion ;
Kema, Ido. P. ;
Garcia, Erwin ;
Connelly, Margery A. ;
Wallimann, Theo ;
Dullaart, Robin P. F. ;
Franssen, Casper F. M. ;
Bakker, Stephan J. L. .
JOURNAL OF HYPERTENSION, 2022, 40 (02) :229-239
[38]   Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites [J].
Rapa, Shara Francesca ;
Di Iorio, Biagio Raffaele ;
Campiglia, Pietro ;
Heidland, August ;
Marzocco, Stefania .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
[39]   Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal [J].
Salzano, Sonia ;
Checconi, Paola ;
Hanschmann, Eva-Maria ;
Lillig, Christopher Horst ;
Bowler, Lucas D. ;
Chan, Philippe ;
Vaudry, David ;
Mengozzi, Manuela ;
Coppo, Lucia ;
Sacre, Sandra ;
Atkuri, Kondala R. ;
Sahaf, Bita ;
Herzenberg, Leonard A. ;
Herzenberg, Leonore A. ;
Mullen, Lisa ;
Ghezzi, Pietro .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (33) :12157-12162
[40]  
Schmaderer Christoph, 2014, Ther Adv Cardiovasc Dis, V8, P80